X0202 3 2005-02-02 0 0001285701 FAVRILLE INC FVRL 0001317235 Alloy Corporate 2000, L.P. 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 1 0 0001169312 SANDERLING V BETEILIGUNGS GMBH & CO KG 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001316917 Sanderling Venture Partners V, LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001160649 SANDERLING V BIOMEDICAL LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001267980 SANDERLING VENTURES MANAGEMENT V 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001316918 Sanderling Venture Partners V Co Investment Fund, LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001139814 SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer 0001298849 Middleton, McNeil & Mills Associates V, LLC 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO CA 94402 0 0 0 1 Joint Filer Common Stock 19274 D Series B Convertible Preferred Stock Common Stock 790042 D Series B-2 Convertible Preferred Stock Common Stock 319756 D Series C Convertible Preferred Stock Common Stock 838132 D The shares are held as follows: 933 shares by Sanderling V Limited Partnership ("SV LP"), 830 shares by Sanderling V Beteiligungs, GmbH & Co. KG ("Beteiligungs"), 9,421 shares by Sanderling Venture Partners V, L.P. ("SVPV"), 2,307 shares by Sanderling V Biomedical, L.P. ("Biomedical") and 5,783 shares by Sanderling V Ventures Management ("SVVM"). Immed. Not applicable. 1-for-1 The shares are held as follows: 54,119 shares by SV LP, 48,155 shares by Beteiligungs, 546,102 shares by SVPV, 133,766 shares by Biomedical and 7,900 shares by SVVM. The shares are held as follows: 21,904 shares by SV LP, 19,490 shares by Beteiligungs, 221,026 shares by SVPV, 54,139 shares by Biomedical and 3,197 shares by SVVM. 1.086614-for-1 The shares are held as follows: 68,604 shares by SV LP, 61,044 shares by Beteiligungs, 96,557 shares by SVPV, 23,651 shares by Biomedical, 8,381 shares by SVVM, 361,021 shares by Sanderling Venture Partners V Co-Investment Fund, L.P. ("Venture Co-Investment"), and 218,874 shares by Sanderling V Biomedical Co-Investment Fund, L.P. ("Biomedical Co-Investment"). Middleton, McNeil & Mills Associates V, LLC ("MMM") is the general partner of SVLP, Beteiligungs, SVPV, Biomedical, Venture Co-Investment and Biomedical Co-Investment. All Reporting Persons disclaim beneficial ownership of shares of Favrille, Inc. stock held by the other Reporting Persons herein, except to the extent of their respective pecuniary interest therein, if any. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, or otherwise, any of the Reporting Persons are the beneficial owners of all of the equity securities covered by this statement. See Exhibit 99 2005-02-09